| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016750 |
| Receipt No. | R000019439 |
| Official scientific title of the study | The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease |
| Date of disclosure of the study information | 2015/03/09 |
| Last modified on | 2018/03/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease | |
| Title of the study (Brief title) | The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease | |
| Region |
|
|
| Condition | ||
| Condition | HCV related chronic liver disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We investigate the efficancy of branched-chain amino acid for HCV related chronic liver disease patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 1) Improvement of insulin resistance
2) Reduction of oxidative stress |
| Key secondary outcomes | 1) Change of HCV-RNA
2) Improvement of loss of zinc 3) Improvement of BTR 4) Incidence of HCC 5) Occurrence of side effect |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients who obtained the consent, administer the BCAA enriched supplement for 12 weeks in addition to the original treatment. containing | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Age, over 20 years old
2) Male and female 3) Patients who has inslin resistance 4) Patients who has no HCC 5) Patients who obtained the consent |
|||
| Key exclusion criteria | 1) Cirrotic patients with BCAA formulation while taking
2) Patients during interferon therapy in chronic hepatitis C, cirrhosis 3) Patients receiving medication for diabetes 4) Patients in the intake of dietary supplements containing the BCAA and zinc 5) Patients for branched-chain amino acids and zinc formulation, with a history of hypersensitivity 6) Pregnant woman and women who may possibly be pregnant, women in nursing |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Isao Hidaka |
| Organization | Yamaguchi Univercity Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 1-1-1 Minamikogushi, Uba, Yamaguchi |
| TEL | 0836-22-2241 |
| isao-h@yamaguchi-u.ac.jp | |
| Public contact | |
| Name of contact person | Isao Hidaka |
| Organization | Yamaguchi Univercity Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 1-1-1 Minamikogushi, Uba, Yamaguchi |
| TEL | 0836-22-2241 |
| Homepage URL | |
| isao-h@yamaguchi-u.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 山口大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019439 |